Maze Therapeutics, Inc. ($MAZE)
Filing Information
| Accession Number | 0002050422-26-000010 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
63,000
Total Value
$278,110.60
P&L
+inf% (+$2,305,440.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, Finance | Common Stock | โ | Mar 2, 2026 | Exercise/Conversion | 5,000 | $10.42 | $52,100.00 | 17,965 | Direct | โ | View Details | |
SVP, Finance | Common Stock | โ | Mar 2, 2026 | Sale | 1,300 | $44.44 | $57,773.82 | 16,665 | Direct | โ | View Details | |
SVP, Finance | Common Stock | โ | Mar 2, 2026 | Sale | 3,700 | $45.47 | $168,236.78 | 12,965 | Direct | โ | View Details | |
SVP, Finance | Stock Option (Right to Buy) | Derivative | Mar 2, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 36,333 | Direct | โ | View Details | |
SVP, Finance | Stock Option (Right to Buy) | Derivative | Mar 2, 2026 | Grant/Award | 32,000 | $0.00 | $0.00 | 32,000 | Direct | โ | View Details | |
SVP, Finance | Restricted Stock Units | Derivative | Mar 2, 2026 | Grant/Award | 16,000 | $0.00 | $0.00 | 16,000 | Direct | โ | View Details |